Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2019		Dec. 31, 2018
Cash flows from operating activities
Net income	$ 6,652		$ 5,615
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	200		0
Depreciation	376		390
Accretion of discount on purchased loans	(145)		(87)
Amortization of CDI	101		109
Earned ESOP shares	0		232
Stock option compensation expense	46		53
Net recoveries on investment securities	(103)		(11)
Change in fair value of investments in equity securities	5		(8)
Gain on sales of OREO and other repossessed assets, net	(39)		0
Provision for OREO losses	0		3
Gain on sales of loans, net	(953)		(386)
Loss (gain) on sales/disposition of premises and equipment, net	99		0
Loans originated for sale	(32,959)		(16,932)
Proceeds from sales of loans	34,563		16,115
Amortization of servicing rights	185		153
Valuation adjustment on servicing rights	24		0
BOLI net earnings	(147)		(157)
Increase in deferred loan origination fees	36		238
Net change in accrued interest receivable and other assets, and other liabilities and accrued expenses	1,632		1,447
Net cash provided by operating activities	9,375		6,774
Cash flows from investing activities
Net decrease in CDs held for investment	2,097		433
Proceeds from sale of investment securities available for sale	0		2,332
Purchase of investment securities held to maturity	(9,755)		0
Purchase of investment securities available for sale	(16,502)		0
Proceeds from maturities and prepayments of investment securities held to maturity	1,946		580
Proceeds from maturities and prepayments of investment securities available for sale	892		644
Increase in loans receivable, net	(26,579)		(10,377)
Additions to premises and equipment	(339)		(984)
Proceeds from sales of premises and equipment	304		0
Cash acquired, net of cash consideration paid in business combination	0		14,284
Escrow deposit for business combination	0		6,900
Proceeds from sales of OREO and other repossessed assets	63		0
Net cash (used in) provided by investing activities	(47,873)		13,812
Cash flows from financing activities
Net increase (decrease) in deposits	16,250		(5,867)
Proceeds from exercise of stock options	170		71
Payment of dividends	(2,086)		(1,911)
Net cash provided by (used in) financing activities	14,334		(7,707)
Net (decrease) increase in cash and cash equivalents	(24,164)		12,879
Cash and cash equivalents, at beginning of period	143,015	[1]	148,864
Cash and cash equivalents, at end of period	118,851		161,743
Supplemental disclosure of cash flow information
Interest paid	1,171		901
Supplemental disclosure of non-cash investing activities
Loans transferred to OREO and other repossessed assets	0		91
Other comprehensive loss related to investment securities	(196)		(79)
Business Combination (see Note 2)
Fair value of assets acquired	0		180,518
Fair value of liabilities assumed	$ 0		$ 154,829

[1] Derived from audited consolidated financial statements.